Clinical Trial Update: Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tamsulosin and/or dutasteride to relieve urinary symptoms after brachytherapy for localized prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Avodart (dutasteride)
• Flomax (tamsulosin hydrochloride)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED